Core Advantage
Access is theMoat.
Every venture inherits what a startup cannot build overnight — direct, standing relationships with the providers and care settings where wounds are actually treated. That access lets us validate in the real world and reach patients at scale from day one. It's where the risk lives, and where we've already worked it down. Access is the moat that makes a wound care opportunity worth backing.
What the access layer enables
Real-world validation inside live care environments, not isolated trials.
Continuous real-world feedback that informs venture development as it happens.
Deployment pathways that are open before a product is finished, not after.
A shared infrastructure every venture on the platform can draw from.
50,000+
Active patient touchpoints
Across embedded care sites
700+
Provider feedback loops across care settings
Prospective observational
50+
Skilled nursing operator partnerships
Operational integration
10,000+
National retail and pharmacy access points
SNF · LTACH · Wound clinic
Why this matters
By operating its own validation infrastructure inside high-volume global care settings, Trulore Catalyst Group generates real-world evidence to the same standard — faster, at lower cost, and across larger patient populations than any single-site domestic study could reach.
